Background: Low back pain (LBP) is a complex syndrome which includes a nociceptive (NcP) component, a neuropathic (NeP) component, or a mixture of components (mixed pain). The NeP component (NePC) in LBP is defined as the presence of NeP with or without an NcP.
neuropathic (NeP), or mixed pain components (mixed pain) (1) . The neuropathic pain component (NePC) in LBP is defined as the presence of NeP either on its own or associated with NcP. Recently, the development of multiple measurement scales, such as the L ow back pain (LBP) is the most frequently observed chronic pain condition (1) . It may be associated with leg pain and/or motor/ sensory/reflex deficits in the nerve root distribution areas. Thus, LBP can present with nociceptive (NcP), www.painphysicianjournal.com painDETECT questionnaire (PDQ) (2) , the neuropathic pain questionnaire (NPQ) (3), the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) (4), the ID-pain (5), the Douleur neuropathique 4 (DN4) (6) , and the standardized evaluation of pain (StEP) (7) have facilitated a better identification of NePC in LBP conditions. The extent of involvement of NePC in LBP patients is extensively debated, with reported prevalence rates being in the range of 28.1% to 71.2% (8, 9) . Recognition of NePC is important, since it may significantly affect the patient's psychological and social functioning, while placing considerable financial demands on society (10) .
Categorizing LBP as either NcP or NeP is not always straightforward (11) . A range of different approaches have been proposed to facilitate this distinction, including physician's judgement, International Association for the Study of Pain (IASP) Treed's criteria (12) , different questionnaires (2) (3) (4) (5) (6) (7) , and finally quantitative sensory (QST) and pharmacological testing methods (13) . Identifying the presence of NePC in LBP is important, since this may present as a challenging treatment/management issue (14) , typically associated with low rates of treatment success (15) . Patients with acute LBP may show NeP symptoms similar to those of chronic LBP (CLBP), with lack of recognition possibly leading to suboptimal drug dosages being administered, with the risk that the acute pain condition may persist and become subacute/ chronic (16, 17) .
The current meta-analysis is aimed at assessing the pooled prevalence of NePC in patients with acute, subacute, and chronic LBP and identifying the factors causing significant heterogeneity in reported prevalence.
Methods

Search Strategy
Two electronic databases (PubMed and EMBASE, from their inception until August 2015) were searched independently by 2 authors without any language restriction. Both full texts and MeSH terms were considered to identify those epidemiological (e.g., case control and cohort) studies focusing on assessing NeP prevalence levels in LBP patients. Searches were conducted using synonyms and combinations of the following search terms: "neuropathic pain," "prevalence," "low back pain," and "leg pain." In addition, related systematic reviews and selected studies' reference lists were screened for any other relevant study to be included in the present analysis.
Study Selection Criteria
Two authors independently reviewed the titles and abstracts of all identified citations as per inclusion and exclusion criteria. An abstract was considered to be relevant if it reported original data, originated from epidemiological studies, and reported the prevalence of NePC in patients with LBP. For the present analysis, patients were classified in 3 groups: a) patients with exclusive NcP, b) patients with exclusive NeP, and c) patients with mixed pain (e.g., suffering from both NeP and NcP). NePC was here defined as presence of NeP symptoms exclusively and/or associated with NcP symptoms.
Studies were excluded if data regarding prevalence of NeP in LBP patients were missing/not clearly reported, and when diagnostic methods were either not standardized or not reported. Single case reports, comments, letters, editorials, protocols, guidelines, and review papers were excluded. When there were multiple publications for the same population, only the most detailed report was included. Any discrepancies were resolved by a consensus conference.
Data Extraction and Synthesis
Two authors independently extracted a range of relevant information, including first author name, year of publication, country of patients' recruitment, study setting, study design, sample size, diagnostic methods used to assess NePC, NeP/NePC reported prevalence rates (PR) and 95% confidence interval (CI), duration of disease, and definitions of NeP, NcP, and NePC. If unavailable, both PR and 95% CI of NeP/NePC were calculated from the raw data available. If a study reported PRs of NeP and mixed pain separately, they were pooled together to get an estimate of NePC.
Quality Assessment
Consistent with the approach of both Hoogendoorn et al (18) and De Vet et al (19) , all included studies were independently assessed for their methodological quality by 2 authors. These researchers had developed and tested a list of 23 criteria to be used to assess the methodological quality of prospective, cohort, and case control studies. Out of this list of criteria, Fishbain et al (20) selected 10 criteria that were deemed appropriate for the assessment of NeP prevalence in LBP. To this list, Fishbain et al (20) have added one extra criterion. We have excluded 5 questions and added one (relating to the characteristics of recruitment, e.g., consecutive or not) question for this study, resulting in a total of 7 criteria , including study design related quality assessment Neuropathic Pain Component in Chronic Low Back Pain (22) . The publication bias was assessed using both the funnel plot and the Begg's test. The Duval and Tweedie nonparametric trim-and-fill method was performed to further assess the effect of potential publication bias, a method which negotiates the lack of studies on a particular side of the funnel (23) . When data were not uniformly reported to allow a formal statistical analysis, we presented the available data in a narrative format. All statistical tests were 2-sided, and a P value < 0.05 was considered statistically significant, except where otherwise specified. Data were analyzed using STATA version 11.0 (StataCorp, College Station, TX, USA).
Results
Search Results
After applying the initial search strategy, a total of 160 citations were identified (Fig. 1) . After reviewing the citations, 124 of them were considered ineligible, as they were reviews/editorials/case reports, hence not meeting the inclusion criteria. In examining the full text of the remaining 36 studies and reviewing the related reference lists, 5 further studies were considered. After a detailed evaluation of these 41 manuscripts, 21 of them were excluded for a range of reasons, which are better detailed in Fig. 1 . As a result, 20 studies were included in the present meta-analysis.
Description of Included Studies
All the studies had been published between 2004 and 2015. Most (n = 10; 50%) originated from Europe (2,7,9,24-30), followed by Asia (n = 5; 25%) (10, 17, (31) (32) (33) , and Africa (n = 4; 20%) (8, (34) (35) (36) . The study sample recruitment site was not reported in one study (37) .
Out of these studies, 17 (85%) were cross sectional, 2 were cohort, and one was a case control study. Eleven (55%) studies were multi-center (2,10,24-27,29-31,34,35) whereas the remaining were single-center studies (7) (8) (9) 17, 28, 32, 33, 36, 37) . Twelve (60%) studies were carried out primarily to assess the prevalence of NeP in patients with LBP, while the remaining focused either on the effects of NeP on a range of patientreported outcomes or on the validation of a range of NeP-related questionnaires. Eighteen (90%) studies included patients with LBP as the main clinical concern, while 2 studies included patients with multiple pain conditions. The LBP etiology was reported in 8 (40%) studies (10, 17, 24, 31, 32, (34) (35) (36) .
All studies were carried out in hospital settings. Most (n = 16) studies had reported a diagnosis of measures like clearly defined objective, standard data collection procedure, and statistical analysis plan. For each of the included studies, each criterion was rated either fulfilled (+), unfulfilled (−), or not applicable (NA). A quality score for each paper was obtained by counting the number of positives obtained; the score was then divided by 7 (minus the number of NAs) and multiplied by 100, providing the percentage quality score. Studies scoring less than 60% were excluded for further review. Any discrepancy in quality assessment was discussed and internally resolved between 2 authors.
Data Synthesis and Analysis
As the primary outcome measure, we calculated the weighed pooled PR of NePC in patients with LBP. The weight, Wi, assigned here to each study was the inverse of the estimated variance. Where different prevalence estimates in the same patient group, using different diagnostic methods, were reported those prevalence estimates resulting from the most reliable method were chosen. For the present meta-analysis, the pooled PR, with 95% CI, was reported as a summary measurement, with the results being presented as a forest plot. Cochran Q and I 2 statistics were used to assess heterogeneity, with a Q statistic P value of < 0.10, and an I 2 value > 50% having been considered as statistically significant. If heterogeneity was identified, the DerSimonian-Laird random-effects model was applied; otherwise, the fixed effects-model (inverse variance) was considered (21) . A pre-specified subgroup analysis was carried out to assess the source of heterogeneity, according to: i) diagnostic method(s) for identification of NeP (e.g., physician-or questionnaire-based), ii) duration of LBP (e.g., acute, subacute, or chronic), iii) presence of associated leg pain, iv) primary objective of the study being/not being the assessment of NeP prevalence, v) number of study centers involved (e.g., single vs multi-center), and vi) questionnaires used for the diagnosis (e.g., LANSS, DN4, PDQ, and NPQ). Tests for interaction using summary estimates were performed, using the method described by Altman and Bland (21) .
To evaluate the stability of our results, we also performed a one-way sensitivity analysis. The scope of this analysis was to evaluate the influence of individual studies by estimating the average PR in the absence of each study. The present work was performed in accordance with the guidelines proposed by the Metaanalysis of Observational Studies in Epidemiology group and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA; supplementary material 1)
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NePC which relied solely on symptom-based questionnaires, while the sole physician's criteria were used in 2 studies (5, 27) . Only one study (7) reported an NePC diagnosis made with the help of both physician's criteria and symptom-based questionnaires. Most commonly used questionnaires included PDQ (n = 7 studies) (2, 9, 17, 25, 26, 28, 33) , followed by DN4 (6, 8, 24, 36, 37) , and LANSS (6,31,32,34,35) (n = 5 each). Conversely, NPQ (n = 2 studies) (10, 33) and StEP (n = 1 study) (7) were less frequently considered (Table 1 ).
Quality Assessment
All the studies had a quality score ranging from 71% to 100%, hence were eligible for inclusion. The average (SD) score was 92.8% (9.8%) ( Table 2) . Two studies presented with a score of 71.4%; in fact, they were not characterized by an adequate sample size (e.g., n < 50 patients) and had not considered a consecutive patient recruitment (10, 33) .
Primary Outcome
As a significant heterogeneity was found between studies (Cochrane Q ≤ 0.01, I 2 = 98), a random effects model was chosen (Table 3 ). The present meta-analysis included 14,269 patients with LBP, of whom 7,969 patients (55.8%) were identified with NePC. The pooled PR (95% CI) of NePC in patients with LBP out of all the included studies was 0.47 (0.40 -0.54) (Fig. 2) , with pooled PR for NePC being in the 0.28 to 0.71 range.
Sensitivity Analysis
The estimated effect size did not deviate much by excluding any study, one at a time, with pooled PR values ranging between 0.42 and 0.49.
Publication Bias
The visual examination of the funnel plot revealed only minimal levels of asymmetry (Fig. 3) . This was further confirmed by the Begg's test (P = 0.58) which indicated little or no publication bias. The NePC pooled PR value (e.g., 0.47; 0.40 -0.54) obtained using the random effects model remained unchanged using the Duval and Tweedie's (23) trim-and-fill analysis.
Sub-group Analysis
With the physician-diagnosis approach, the pooled 
Secondary Outcomes
The pooled PR of mixed pain in patients with LBP (n = 7 studies) was found to be 0.28 (0.23 -0.34) (Table 4) 
discussion
The present meta-analysis of 20 studies, including 14,269 participants, found that the PPR of NePC in patients with LBP was 47% (40% -54%), hence NePC may need to be considered as a significant clinical problem in these patients. One of the major strengths of the current study is that we focused on both the neuropathic and the nociceptive components, while considering not only the chronic, but also the acute/ subacute, LBP conditions. Moreover, previous studies considered mathematic calculations only to estimate NePC pooled PR values, as opposed to the formal meta-analysis approach which was carried out here. The NePC figure (47%) identified is consistent with previous findings, e.g., Morso et al (45.5) and Ouedraogo et al (49.5) (28,36), but it is at odds with the figures reported by both Fishbain et al (36.6%) and Mehra et al (90.4%) (20, 38) . The studies here reported a prevalence of NePC ranging from 28.1% to 71.2%, with these levels Table 2 Neuropathic Pain Component in Chronic Low Back Pain of variations possibly being explained by differences in inclusion criteria, sample size, study settings, and diagnostic methods used (8, 9) . Furthermore, some diagnostic questionnaires fail to identify the mixed pain conditions, hence underestimating the presence of NeP symptoms (31, 35, 36) . According to the current sensitivity analysis, excluding any single study did not have here any major impact on the combined results, which may well suggest that the present meta-analysis results are pretty consistent. Furthermore, both a robustness of results and lack of publication bias were confirmed. Overall, a physician/clinician decision is considered to be the gold standard in diagnosing any type of pain, with the diagnostic accuracy of screening questionnaires not always being considered satisfactory (39) . However, similar NePC prevalence levels were identified in those studies using questionnaires (0.48; 0.40 -0.55) vs those considering the clinician-based diagnosis (0.44; 0.32 -0.55).
LBP duration was hypothesized to be a possible factor associated with different NePC prevalence levels. However, the NePC PPR value was only marginally higher in patients with CLBP than in those experiencing acute/subacute LBP (respectively: 0.49; 0.41 -0.57; vs 0.45; 0.28 -0.62; ns). Indeed, acute and chronic LBP cases differ in their etiology and pathophysiology, with acute LBP being usually a self-limiting, protective, biological function of on-going tissue damage. Acute pain is mostly nociceptive in origin and occurs secondary to stimulation of A-delta and C-polymodal pain receptors (16) . Conversely, CLBP is in itself a disease process which can persist for years after the initial injury and which can be refractory to multiple treatment modalities. Inadequately treated acute pain conditions may be asso-www.painphysicianjournal.com ciated with NeP symptoms (16) and may become chronic. Consistent with this, a higher prevalence of NePC is typically identified in CLBP as opposed to acute/subacute LBP (17) .
The presence of leg pain was hypothesized as another possible factor associated with different NePC prevalence levels. As expected, and consistent with previous findings (17), the NePC prevalence was significantly higher in patients affected by leg pain than in those with uncomplicated LBP. Although both NeP and NcP mechanisms are thought to contribute to leg pain in LBP, neuropathic mechanisms play a more significant role (1, 27) Evidence also suggests that patients experiencing a radiating leg pain may complain of intense pain and significant disability (40) , delayed recovery, and a tendency to chronicity (41) . Furthermore, they frequently require surgical interventions for their LBP to be managed (42). To better identify the presence of NePC in LBP, some questionnaires (e.g., PDQ) have been designed to specifically include a question about the presence of leg pain (12) . Results of the present meta-analysis might not be generalizable to patients with failed back syndrome where the prevalence of NeP is more common and the cause for NeP is quite different.
Limitations
The quality of the studies selected was assessed using an ad hoc, customized scale. Although not specifically validated, the scale presented has been designed while including further assessment criteria to previous instruments. Due to the limited number of available Neuropathic Pain Component in Chronic Low Back Pain studies, one may need to be cautious in concluding about the impact of disease duration on NePC prevalence values. Furthermore, the quality of data collected from those studies whose primary aim was not the assessment of NeP prevalence may be questionable. Similarly, one could wonder about the appropriateness of grouping together studies which used a range of different diagnostic methods, with putatively different sensitivity/specificity diagnosing levels. To address this issue, however, a subgroup analysis based on type of questionnaires used was carried out. The limitation of current diagnostic methods is that we cannot quantify how much neuropathic there is vs. nociceptive to direct the clinician to the appropriate therapy. The studies included did not present with sufficient data to perform a subgroup analysis to estimate NeP prevalence levels according to specific clinical conditions/pathologies involved. Finally, only a few studies included patients with LBP with an associated leg pain condition (9, 28, 30) , so that the results presented may need to be interpreted with some caution. There are limited studies from the US.
Given the difficulties in treating and managing clients affected by low back pain with a neuropathic component further research studies with larger sample sizes and increased diagnostic accuracy levels should be promoted. As pain is subjective phenomenon and as there is a lack of a gold standard for the diagnosis of NP, there is the possibility that the pooled effect estimate may alter if the diagnostic ability of the available and used methods warrant the gold accuracy.
